厌氧菌对环丙沙星（拜奥9867）的体外敏感性
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
作者信息
Prabhala R H, Rao B, Marshall R, Bansal M B, Thadepalli H
出版信息
Antimicrob Agents Chemother. 1984 Nov;26(5):785-6. doi: 10.1128/AAC.26.5.785.
Abstract
About 80% of 70 clinical isolates of Bacteroides fragilis were inhibited by 4 micrograms of ciprofloxacin (Bay o 9867) per ml. The 90% MIC of ciprofloxacin was 8 micrograms/ml for other Bacteroides species, 2 micrograms/ml for Peptococcus species, 8 micrograms/ml for Peptostreptococcus species, and 16 micrograms/ml for Clostridium and Eubacterium species.
摘要
每毫升含有4微克环丙沙星（拜耳o 9867）时，70株脆弱拟杆菌临床分离株中约80%受到抑制。环丙沙星对其他拟杆菌属细菌的90%最小抑菌浓度为8微克/毫升，对消化球菌属细菌为2微克/毫升，对消化链球菌属细菌为8微克/毫升，对梭菌属和真杆菌属细菌为16微克/毫升。
相似文献
1
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).厌氧菌对环丙沙星（拜奥9867）的体外敏感性
Antimicrob Agents Chemother. 1984 Nov;26(5):785-6. doi: 10.1128/AAC.26.5.785.
2
Is ciprofloxacin active against clinically important anaerobes?
J Antimicrob Chemother. 1986 May;17(5):605-13. doi: 10.1093/jac/17.5.605.
3
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.接种量、pH值和培养基对环丙沙星抗厌氧菌活性的影响。
Antimicrob Agents Chemother. 1984 Mar;25(3):342-3. doi: 10.1128/AAC.25.3.342.
4
In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.新型头孢霉素头孢哌酮对厌氧菌的体外活性
Antimicrob Agents Chemother. 1985 Apr;27(4):640-2. doi: 10.1128/AAC.27.4.640.
5
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.新型氯氟喹诺酮BAY y 3118与环丙沙星、司帕沙星及其他抗菌药物相比，对厌氧菌的活性增强。
Antimicrob Agents Chemother. 1994 Jul;38(7):1671-4. doi: 10.1128/AAC.38.7.1671.
6
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星，一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
7
In vitro activity of BAY 12-8039, a new fluoroquinolone.新型氟喹诺酮类药物BAY 12 - 8039的体外活性
Antimicrob Agents Chemother. 1997 Jan;41(1):101-6. doi: 10.1128/AAC.41.1.101.
8
In vitro activities of three of the newer quinolones against anaerobic bacteria.三种新型喹诺酮类药物对厌氧菌的体外活性
Antimicrob Agents Chemother. 1992 Jan;36(1):239-43. doi: 10.1128/AAC.36.1.239.
9
Comparative activity of ciprofloxacin against anaerobic bacteria.环丙沙星对厌氧菌的比较活性。
Antimicrob Agents Chemother. 1985 Mar;27(3):427-8. doi: 10.1128/AAC.27.3.427.
10
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.428株革兰氏阳性和阴性厌氧菌对Bay y3118的敏感性及其对环丙沙星、克林霉素、甲硝唑、哌拉西林、哌拉西林-他唑巴坦和头孢西丁的敏感性比较。
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
引用本文的文献
1
The Rise, Fall, and Rethink of (Fluoro)quinolones: A Quick Rundown.（氟）喹诺酮类药物的兴衰与重新审视：简要概述
Pathogens. 2025 May 24;14(6):525. doi: 10.3390/pathogens14060525.
2
Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents.喹诺酮类的生物学效应：一类广谱抗菌药物。
Molecules. 2021 Nov 25;26(23):7153. doi: 10.3390/molecules26237153.
3
Loading and Releasing Ciprofloxacin in Photoactivatable Liposomes.光活化脂质体中ciprofloxacin的负载与释放
Biochem Eng J. 2019 Jan 15;141:43-48. doi: 10.1016/j.bej.2018.10.008. Epub 2018 Oct 11.
4
Quinolone activity against anaerobes.喹诺酮对厌氧菌的活性。
Drugs. 1999;58 Suppl 2:60-4. doi: 10.2165/00003495-199958002-00012.
5
In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.曲伐沙星（CP-99,219）的体内疗效，一种对革兰氏阳性病原体、肺炎链球菌和脆弱拟杆菌具有广泛活性的新型喹诺酮类药物。
Antimicrob Agents Chemother. 1995 Oct;39(10):2210-6. doi: 10.1128/AAC.39.10.2210.
6
Quinolone activity against anaerobes: microbiological aspects.喹诺酮对厌氧菌的活性：微生物学方面。
Drugs. 1995;49 Suppl 2:76-80. doi: 10.2165/00003495-199500492-00012.
7
The place of quinolones in antibacterial therapy in hospitals.喹诺酮类药物在医院抗菌治疗中的地位。
Pharm Weekbl Sci. 1986 Feb 21;8(1):72-8. doi: 10.1007/BF01975485.
8
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.环丙沙星与克林霉素、甲硝唑、头孢西丁、头孢噻肟和美洛西林对革兰氏阳性和革兰氏阴性厌氧菌的相互作用。
Antimicrob Agents Chemother. 1987 Sep;31(9):1379-82. doi: 10.1128/AAC.31.9.1379.
9
Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.双氟沙星（A-56619）和A-56620对临床厌氧菌的体外活性。
Antimicrob Agents Chemother. 1987 Apr;31(4):619-21. doi: 10.1128/AAC.31.4.619.
10
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.地氟沙星（A-56619）和A-56620对实验性诱导的脆弱拟杆菌相关性腹腔内脓肿的治疗评估。
Antimicrob Agents Chemother. 1986 Oct;30(4):574-6. doi: 10.1128/AAC.30.4.574.
本文引用的文献
1
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
2
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.环丙沙星（拜奥9867）、诺氟沙星、吡哌酸和萘啶酸的比较活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
3
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
4
Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure.通过简化的手套箱程序从人牙龈和小鼠盲肠中分离厌氧细菌。
Appl Microbiol. 1969 Apr;17(4):568-76. doi: 10.1128/am.17.4.568-576.1969.
5
In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.替卡西林对厌氧菌的体外活性与羧苄西林和青霉素的比较。
Antimicrob Agents Chemother. 1977 Feb;11(2):258-61. doi: 10.1128/AAC.11.2.258.
Zotero 插件